Hospital Sant Joan de Déu

Esplugues de Llobregat, Barcelona 08950

2 studies enrolling now · 4 studies all time

What they study most

Duchenne Muscular Dystrophy, Neuroblastoma, Otoferlin Gene-mediated Hearing Loss, Plaque Psoriasis

Studies at this site

• Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma — Recruiting now
• Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy — Running, not enrolling
• Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy — Enrolling by invitation
• Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis — Completed